Medicare prescription drug cost, prescriptions and prescribers, 2024
Medicare cost, 2024
$238.9M
+16.6% from 2023
Prescriptions
335K
$714.13 per claim
Patients
117K
54,169 prescribers
Total spending, 2024
$239.0M
$2,044.91 per patient
Medicare prescription drug plans paid $238.9M for Lokelma in 2024, for 334,577 prescriptions and refills to 116,835 patients (up 16.6% from 2023). The average cost per claim was $714.13.
California had the highest Medicare cost for Lokelma in 2024: $37.5M for 46,532 claims, followed by New York ($26.4M).
Paul-Moreau Bossous, nephrology in Mission, TX, had the highest Medicare cost for Lokelma in 2024: 283 claims costing $461K.
Lokelma is made by AstraZeneca PLC (AZN), listed in the Medicare spending data as Astrazeneca.
All plans and makers
Where the prescribers practice, 2024
By Medicare drug cost
| Prescriber | Type | Claims | Patients | Cost |
|---|---|---|---|---|
| Paul-Moreau Bossous Mission, TX | Nephrology | 283 | 121 | $461K |
| Khin S Yee Fresno, CA | Nephrology | 234 | 70 | $283K |
| Victor G Carabello Los Angeles, CA |
| Year | Prescribers | Claims | Patients | Cost |
|---|---|---|---|---|
| 2022 | 36,946 | 220,902 | 77,794 | $160.3M |
| 2023 | 44,617 | 272,399 | 94,692 | $204.9M |
| 2024 | 54,169 | 334,577 | 116,835 | $238.9M |
Amount reimbursed by state Medicaid programs, all states
More drugs: top Medicare drugs by cost and the Prescriptions tab.
Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.
| Internal Medicine |
| 300 |
| 56 |
| $243K |
| Kay K Kyaw Montebello, CA | Nephrology | 306 | 45 | $231K |
| Ramon A Seneriz Olivencia San Juan, PR | Nephrology | 261 | 66 | $220K |
| Sheri A Pham Covina, CA | Internal Medicine | 265 | 53 | $219K |
| Anthony P Blalock Lafayette, LA | Nephrology | 307 | 71 | $219K |
| Savita Koolwal Pharr, TX | Internal Medicine | 201 | 58 | $207K |
| Jill M Meyer Chula Vista, CA | Nephrology | 249 | 66 | $204K |
| Padma Yarlagadda San Jose, CA | Nephrology | 206 | 82 | $199K |
| Sonia C Simoes Newark, NJ | Nephrology | 140 | 44 | $199K |
| Raffi R Minasian Glendale, CA | Nephrology | 222 | 50 | $198K |
| Varun Chawla Fremont, CA | Nephrology | 146 | 37 | $195K |
| Rafael Khaim New York, NY | Nurse Practitioner | 224 | 69 | $195K |
| Kin Wong Los Angeles, CA | Internal Medicine | 241 | 32 | $194K |
| Alla Maslova Brooklyn, NY | Nephrology | 215 | 58 | $185K |
| Nurudeen D Mahama Yuma, AZ | Nurse Practitioner | 184 | 78 | $182K |
| Karla I Menjivar Los Angeles, CA | Nurse Practitioner | 214 | 38 | $180K |
| Franklin D Ponce Herrera McAllen, TX | Nephrology | 173 | 63 | $178K |
| Elizabeth Liang Flushing, NY | Nephrology | 278 | 60 | $175K |
| Lisa O Cabrera San Antonio, TX | Nephrology | 215 | 58 | $173K |
| Farhad Ghanaat Brooklyn, NY | Internal Medicine | 135 | 47 | $169K |
| Carlos R Gonzalez Montebello, CA | Nephrology | 181 | 34 | $162K |
| Samir Sutaria Edison, NJ | Nephrology | 164 | 34 | $161K |
| Jose B Esquenazi Miami, FL | Internal Medicine | 171 | 32 | $158K |
Spending by manufacturer as listed in the spending data
| Manufacturer | Claims | Spending |
|---|---|---|
| Astrazeneca AZN | 334,671 | $239.0M |